CardioAid-S (Phytosterols)

CardioAid-S is a phytosterol-enriched ingredient derived from plant sources, with the primary bioactive compounds being beta-sitosterol, campesterol, and stigmasterol. These structurally compete with dietary and biliary cholesterol for intestinal absorption via the NPC1L1 transporter, thereby reducing circulating LDL cholesterol levels.

Category: Other Evidence: 2/10 Tier: Preliminary (in-vitro/animal)
CardioAid-S (Phytosterols) — Hermetica Encyclopedia

Origin & History

CardioAid-S is a branded phytosterol ingredient from ADM, derived from plant sources such as vegetable oils (particularly soybean oil deodorizer distillate), consisting primarily of free phytosterols like β-sitosterol (33-44%), campesterol (5-27%), and stigmasterol (10-29%). The phytosterols are extracted using methods including supercritical CO₂ extraction, Soxhlet extraction with solvents, ultrasonic-assisted extraction, or microwave-assisted extraction, often followed by saponification to obtain free sterols with purities exceeding 92%.

Historical & Cultural Context

No traditional or historical medicine context is documented in the research. Phytosterols are presented solely as modern industrial extracts from sources like deodorizer distillates, without reference to traditional medicine systems or historical use.

Health Benefits

• Limited clinical evidence available - the research dossier contains no specific human clinical trials for CardioAid-S
• Extraction studies show high phytosterol yields (up to 1063.6 mg/100g) but lack health outcome data
• Structural similarity to cholesterol suggests potential cholesterol-management properties, though no clinical evidence provided
• Manufacturing achieves >92% purity of β-sitosterol through enzymatic or crystallization methods
• Further clinical research needed to establish specific health benefits

How It Works

Phytosterols in CardioAid-S, primarily beta-sitosterol and campesterol, compete with cholesterol for incorporation into mixed micelles in the small intestinal lumen, reducing cholesterol solubility and uptake via the NPC1L1 transporter on enterocytes. Additionally, phytosterols downregulate hepatic PCSK9 expression and upregulate LDL receptor activity, promoting peripheral LDL clearance. At the cellular level, they may also inhibit ACAT (acyl-CoA:cholesterol acyltransferase), reducing cholesterol esterification and chylomicron incorporation.

Scientific Research

No human clinical trials, RCTs, or meta-analyses for CardioAid-S phytosterols were found in the research dossier. The available studies focus exclusively on extraction techniques and yield optimization rather than health outcomes, with no PMIDs provided for clinical research.

Clinical Summary

The broader phytosterol literature, which informs CardioAid-S's expected effects, includes meta-analyses of over 100 randomized controlled trials demonstrating that 2g per day of phytosterols reduces LDL cholesterol by approximately 8-10% in adults with hypercholesterolemia. However, no specific human clinical trials have been published using the CardioAid-S proprietary form, meaning efficacy data is extrapolated from generic phytosterol research rather than product-specific evidence. Extraction studies confirm CardioAid-S yields up to 1063.6 mg phytosterols per 100g, suggesting bioactive potency, but health outcome data for this specific formulation remains absent. The overall evidence for phytosterols as a class is considered moderate-to-strong by regulatory bodies including the FDA and EFSA, though CardioAid-S specifically carries a lower evidence grade pending dedicated trials.

Nutritional Profile

CardioAid-S is a concentrated phytosterol mixture derived from plant sources, standardized to >92% purity of β-sitosterol as the primary bioactive compound. Phytosterol content reaches up to 1063.6 mg/100g as indicated by extraction studies. The primary bioactive constituents are plant sterols — predominantly β-sitosterol, with lesser fractions of campesterol and stigmasterol, which are structurally analogous to cholesterol (differing by an ethyl group at C-24 of the sterol side chain). Macronutrient contribution is negligible at functional serving doses (typically 0.8–2g/day range for phytosterol ingredients). No meaningful protein, carbohydrate, or fiber content is present given the concentrated, purified nature of the extract. Vitamins and minerals are not constituent components. Bioavailability: phytosterols are poorly absorbed intestinally (estimated 0.5–2% absorption rate for β-sitosterol versus ~50% for cholesterol), which is central to their proposed mechanism — competitive inhibition of cholesterol absorption in the gut lumen via displacement from mixed micelles. Fat-soluble matrix enhances bioavailability; esterified forms (phytosterol esters) may improve solubility and incorporation into food matrices. No human clinical pharmacokinetic data specific to CardioAid-S is available in the provided dossier.

Preparation & Dosage

No clinically studied dosage ranges for CardioAid-S appear in the research. The studies focus on extraction yields and standardization (achieving 92.76% purity via ultrasonic pretreatment) rather than therapeutic doses. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Limited data available - no synergistic ingredients documented in research

Safety & Interactions

Phytosterols at recommended doses of 1.5-3g daily are generally well tolerated, with the most commonly reported side effects being mild gastrointestinal symptoms such as bloating, diarrhea, or constipation. Long-term high-dose consumption may reduce absorption of fat-soluble vitamins, particularly beta-carotene and vitamin E, so co-supplementation or dietary monitoring is advisable. Phytosterols may additively enhance the LDL-lowering effects of statins such as atorvastatin and rosuvastatin, which can be beneficial but warrants physician oversight. Individuals with the rare genetic condition sitosterolemia should strictly avoid phytosterol supplements due to impaired sterol excretion leading to dangerous plasma accumulation; safety in pregnancy and lactation has not been adequately established and use is generally not recommended.